Clinical Trials Directory

Trials / Sponsors / Argos Therapeutics

Argos Therapeutics

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedTumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC
Kidney Cancer, Renal Cell Carcinoma, Advanced Renal Cell Carcinoma
—2013-08-01
TerminatedPhase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcin
Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 32012-11-01
TerminatedA Rollover Protocol for Subjects Previously Treated With AGS-003
Renal Cell Carcinoma
Phase 22011-09-01
CompletedSafety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
HIV Infection
Phase 22010-07-01
CompletedAn Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)
Inflammation, Systemic Lupus Erythematosus (SLE)
Phase 12009-07-01
CompletedPhase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected Wi
HIV Infections
Phase 22008-02-01
CompletedStudy Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advance
Renal Cell Carcinoma
Phase 22008-01-01
CompletedA Single-Patient Study Using AGS 006
Pancreatic Cancer
N/A2007-05-01
CompletedStudy Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage
Renal Cell Carcinoma
Phase 1 / Phase 22006-01-01
CompletedRNA-Loaded Dendritic Cell Cancer Vaccine
Renal Cell Carcinoma
Phase 1 / Phase 22004-01-01